Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.
about
Validation of an LC/MS method for the determination of gemfibrozil in human plasma and its application to a pharmacokinetic studyThe role of metabolites in predicting drug-drug interactions: focus on irreversible cytochrome P450 inhibition.CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast.Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide.Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinideInteraction between gemfibrozil and warfarin: case report and review of the literature.Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro.Towards safer and more predictable drug treatment--reflections from studies of the First BCPT Prize awardee.Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions.Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters.Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance.Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast.Gemfibrozil impairs imatinib absorption and inhibits the CYP2C8-mediated formation of its main metabolite.
P2860
Q33746585-0F132615-286B-4B84-90BF-97BCADB65F3AQ33967634-590CEB46-DA2B-495A-ADA6-0DE7611F64E3Q35718619-20DE569D-691B-41CA-B0A7-D368BC3D43ACQ35827146-B9299251-1B1F-4BA8-934D-538D46C96156Q35827882-938EE61A-C6A8-4B74-8226-492F33CC70C3Q37498881-48F161E8-F60A-473B-A2AC-07D82628C078Q37534607-481FDEEA-64F6-469C-BE6D-5D31C0A62002Q37986145-21C60313-7B85-474A-8832-2F891DAEF0E1Q38684505-5365A10B-658A-4666-BE06-ABDF12CA9BBDQ38933872-CDDE5BD8-9FB7-4261-A35A-5556CA58527CQ39175937-36B1F252-1BF9-415A-978A-6D845FCB6F04Q42997336-5F4A2788-399A-4BAC-BD4D-E7C1A451A33CQ46431899-EF99907A-9A82-420D-BE34-89638AA9CA75
P2860
Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Effect of gemfibrozil on the p ...... warfarin in healthy subjects.
@ast
Effect of gemfibrozil on the p ...... warfarin in healthy subjects.
@en
type
label
Effect of gemfibrozil on the p ...... warfarin in healthy subjects.
@ast
Effect of gemfibrozil on the p ...... warfarin in healthy subjects.
@en
prefLabel
Effect of gemfibrozil on the p ...... warfarin in healthy subjects.
@ast
Effect of gemfibrozil on the p ...... warfarin in healthy subjects.
@en
P2860
P1476
Effect of gemfibrozil on the p ...... warfarin in healthy subjects.
@en
P2093
Jari J Lilja
P2860
P304
P356
10.1111/J.1365-2125.2004.02323.X
P407
P577
2005-04-01T00:00:00Z